Literature DB >> 9895245

Isolated Norrie disease in a female caused by a balanced translocation t(X,6).

F M Meire1, B A Lafaut, F Speleman, M Hanssens.   

Abstract

This is the second report of Norrie disease in a female patient with a de-novo balanced translocation t(X,6) with breakpoint at the location of the Norrie gene. At the age of 3 months, a girl was referred for suspected congenital glaucoma. The right eye was microphthalmic and ultrasonography was compatible with persistent hyperplasia of the primary vitreous. The left eye was also microphthalmic. The left cornea was larger than the right. The anterior chamber was virtual and leukocoria was evident. The eye felt hard digitally. Ultrasonography indicated an organized retinal detachment. The pathologic findings are reported and are compatible with Norrie disease.

Entities:  

Mesh:

Year:  1998        PMID: 9895245     DOI: 10.1076/opge.19.4.203.2306

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  4 in total

1.  Bilateral persistent fetal vasculature due to a mutation in the Norrie disease protein gene.

Authors:  Seyedmehdi Payabvash; Jill S Anderson; David R Nascene
Journal:  Neuroradiol J       Date:  2015-10-12

2.  Molecular and clinical studies of X-linked deafness among Pakistani families.

Authors:  Ali M Waryah; Zubair M Ahmed; Munir A Bhinder; Munir A Binder; Daniel I Choo; Robert A Sisk; Mohsin Shahzad; Shaheen N Khan; Thomas B Friedman; Sheikh Riazuddin; Saima Riazuddin
Journal:  J Hum Genet       Date:  2011-06-02       Impact factor: 3.172

3.  Next-generation sequencing reveals a case of Norrie disease in a child with bilateral ocular malformation.

Authors:  Haijun Li; Zhiming Li; Degang Wang; Chuanming Chen; Zhiqiang Chen; Jinhua Wang; Chenxia Xu; Xingsheng Dong
Journal:  Front Genet       Date:  2022-08-12       Impact factor: 4.772

4.  Detection of leukocoria using a soft fusion of expert classifiers under non-clinical settings.

Authors:  Pablo Rivas-Perea; Erich Baker; Greg Hamerly; Bryan F Shaw
Journal:  BMC Ophthalmol       Date:  2014-09-09       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.